DNA Technology for NIPT, NIPT Die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA. 5200 Illumina Way Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. Host: https://www.illumina.com | Employer Identification No.) of Rare & Undiagnosed Diseases, Cellular & Molecular This document is not a substitute for the consent solicitation statement/prospectus or Registration Statement or any other document which the Company may file with the SEC. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. PR@illumina.com. Jennifer Temple. is Key to Noninvasive Prenatal Testing, Study Seoul Korea 07325 Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA. NGS to Study Rare Undiagnosed Genetic Disease, Progress Computershare Trust Company, N.A. 858.291.6421. ir@illumina.com. E-mail: ir@illumina.com, Transfer Agent You can reach over 500 investor presentations for your trading. © 2020 Illumina, Inc. All rights reserved. customerservice@illumina.com Contact Illumina Investor Relations – (408) 594‐9328 Q419 Non‐GAAP Financial Highlights You are encouraged to review the GAAP reconciliation of the following non‐GAAP measures at … For specific trademark information, see www.illumina.com/company/legal.html. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Services, Training & Consulting, Illumina Stockholm's Subway Microbiome, Commercial Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. 250 Royall Street Statement of Changes in Beneficial Ownership, PDF Format Download (opens in new window), Word Format Download (opens in new window), Excel Format Download (opens in new window). Terms of the settlement benefit both parties, and the supply agreement has been extended until 2030. Webinars & Online Training, AmpliSeq 858.291.6421 ir@illumina.com. for Illumina Comprehensive Cancer Panel, Breast These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the consent solicitation statement/prospectus that is included in the Registration Statement. Custom Assay Designer, Instrument While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Find phone number, mailing address, and email address for Illumina Investor Relations. HD Custom Genotyping BeadChips, How It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Bioinformatics Applications, Illumina Agricultural Greater Good Grant Winner, Gene Form. Takes a Look at Fetal Chromosomal Abnormalities, iHope for Rare Pediatric Diseases, Rare Partnership on NGS Infectious Disease Solutions, Mapping for Patients with Rare and Undiagnosed Genetic Diseases. Email Alerts; Latest Presentation. Phone: 858-882-2080 Proxy Sie wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation Sequencing. Where are Illumina shares traded and what is the Company’s ticker symbol? Die dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird. Ranking Top30 ! By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. for Illumina Cancer Hotspot Panel v2, AmpliSeq Roche is attempting a hostile take-over of Illumina: The offer price of $51.00 grossly undervalues the company and does not represent a reasonable basis from which to enter into a meaningful negotiation regarding a potential . 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay, 2020 Agricultural Greater Good Initiative Winner shares how grant will improve crop yield and insect resistance, Powerful tools for studying the transcriptome in an unbiased manner from minimal input, All vs Traditional Aneuploidy Screening Methods, SNP RNA Prep with Enrichment, TruSight transaction. the Mysterious World of Microbes, IDbyDNA Tools & Links. Important risk factors that may cause such a difference include, but are not limited to: (i) the proposed transaction may not be completed on anticipated terms and timing, (ii) a condition to closing of the transaction may not be satisfied, including obtaining regulatory approvals, (iii) the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the Company’s business after the consummation of the transaction, (iv) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction, (v) any negative effects of the announcement, pendency or consummation of the transaction on the market price of the Company’s common stock and on the Company’s operating results, (vi) risks associated with third-party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (vii) the risks and costs associated with the integration of, and the ability of the Company to integrate, GRAIL’s business successfully and to achieve anticipated synergies, (viii) the risks and costs associated with the development and commercialization of, and the Company’s ability to develop and commercialize, GRAIL’s products; (ix) the risk that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations, (x) legislative, regulatory and economic developments, (xi) the other risks described in the consent solicitation statement/prospectus that is included in the Registration Statement, as well as in the Company’s most recent annual reports on Form 10-K and quarterly reports on Form 10-Q and in the registration statement on Form S-1 filed with the SEC by GRAIL on September 9, 2020, as amended on September 17, 2020, and (xii) management’s response to any of the aforementioned factors. illumina Investor Relations Investor Presentation. with Challenging Cancers to Benefit from Sequencing, Cell-Free 02-740-5300 (tel) Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Accelerator Startup Funding, Support Bull Genome Sequencing, 2020 Die nächsten Veröffentlichungstermine entnehmen Sie bitte dem Finanzkalender. Top50 ! Email. Form 10-K. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Additional Information and Where to Find It Contributions of Cognitive Control, Mysteries Der gesamte ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen. Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham@illumina.com . Illumina Investor Presentation May 3, 2018. Complex Disease Research Products, NIPT is now recommended for all pregnancies regardless of age or risk, New library prep kits enhance research in rare genetic diseases, Illumina, Inc., Investor Relations Oncology 500 Product Family, Peer-Reviewed Nachstehend finden Sie die Finanzberichte der RIB Gruppe. Eine Übersicht über die Konzernzahlen finden Sie hier. Phone: (858) 882 6822. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library INVESTORS AND SECURITY HOLDERS OF GRAIL ARE URGED TO READ THE REGISTRATION STATEMENT, WHICH INCLUDES THE CONSENT SOLICITATION STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. You can sign up for additional alert options at any time. The Company’s common stock is traded on the NASDAQ Stock Market under the symbol ILMN. 30.10.2020 - Quartalsmitteilung: Januar - September 2020 . Harvard Pilgrim Philip Tracey philip_tracey@harvardpilgrim.org. 800.251.4215 www.computershare.com. Array Identifies Inherited Genetic Disorder Contributing to IVF 2 Safe Harbor Statement This communication may contain forward-looking statements that involve risks and uncertainties, including our financial outlook and guidance for fiscal 2018 and expectations regarding the development and commercialization of new products. All trademarks are the property of Illumina, Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html. By using the investor presentation, you will find growth stocks and preferred stocks. lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. Retailer Reg: 2019-서울영등포-2018 | GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.45–$6.65 Amortization of acquired intangible assets 0.19 Non-cash interest expense (b) 0.28 Incremental non-GAAP tax expense (c) (0.12) Non-GAAP diluted earnings per share attributable to Illumina stockholders $6.80–$7.00 (a) This guidance does not include any impact resulting from the termination of our … Illumina Contact Details. Natera will receive a license to Illumina's intellectual property for use in NIPT using the Illumina sequencing platform. Target Identification & Pathway Analysis, TruSeq For Research Use Only. After submitting your request, you will receive an activation email to the requested email address. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “may,” “target,” similar expressions and variations or negatives of these words. Illumina Investor Relations Source Book - July 2019 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. What is Illumina’s CUSIP number for its common stock? Genetic Data Matchmaking Service for Researchers, Using This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. I confirm that I have read the terms of this website. Terms and Conditions | ! Tax Reg: 105-87-87282 | Durch Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden. PDF 236.99 KB . Phone: 800.251.4215 Executive Summary. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. For Research Use Only. In connection with the proposed transaction, the Company has filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus with respect to the Company’s common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRAIL, Inc. (“GRAIL”) in connection with the proposed transaction. Studies Help Refine Drug Discovery, Identifying Computershare Trust Company, N.A. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.   Investor Relations Contact, Recent Investor Presentation At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Rebecca Chambers. Ranking Top50! Illumina, Inc., Investors Relations 5200 Illumina Way San Diego, CA 92122. and Potential of NGS in Oncology Testing, Breast Strong Q3 Results: Illumina’s impressive third-quarter 2020 results instill investor confidence in the stock. The Company may also file other documents with the SEC regarding the proposed transaction. Sr. Director, Investor Relations. lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. Publication Summaries, Specialized Download [3.20 MB] Free! Illumina, Inc. ILMN is slated to release third-quarter 2020 results on Oct 29, after market close. Panels in Brain Tumor Studies, The Investor Relations. Prep & Array Kit Selector, DesignStudio This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. Whole-Genome Sequencing, Microbiome Cautionary Notes on Forward-Looking Statements Whole Transcriptome Analysis 3' Library Prep Kit, Genetic The gradually improving business … 66 Yeoidaero Yeoungdeungpo-gu Manager, Public Relations. No Registration! Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation or organization) (I.R.S. Finanz berichte. November 12, 2020. 14F KTB Building Source: Illumina, Inc. Methyl Capture EPIC Library Prep Kit, SureCell Contact Us. Konzernzahlen; Los. Illumina Investor Relations Source Book - November 2018 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Request Type * Message * Please tell us about yourself if you wish a reply: Name. 投稿日: 5月 9, 2019. Agricultural Applications, iSelect The tender offer is blatantly opportunistic, timed to take advantage of a temporary . Investor Relations Finanzberichte. Die DNA wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. Catalyze Patient Access to Genomic Testing, Patients Biology Research, In Last Week, Illumina (ILMN)-owned GRAIL announced that it has formed a partnership with the UK’s National Health Service (NHS). Agricultural Greater Good Grant Winner, 2019 02-786-8368 (fax) Finanzberichte 2020. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. You must click the activation link in order to complete your subscription. Cancer Target Identification, Partnerships into Recurrent Pregnancy Loss, Education No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, andotherwise in accordance with applicable law. Not for use in diagnostic procedures (except as specifically noted). Public Relations. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, credit rating or liquidity. Not for use in diagnostic procedures (except as specifically noted). To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Vitro Diagnostic (IVD) Products, Challenges Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. If you experience any issues with this process, please contact us for further assistance. Corporate Website: http://www.computershare.com, Email Alerts All trademarks are the property of Illumina, Inc. or their respective owners. No Offer or Solicitation Multidrug-Resistant Tuberculosis Strains, Investigating Investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020. San Diego, CA 92122 SEC Filings; Corporate Citizenship; Q2’20 Earnings Results ; Innovative technologies. Transfer Agent. Failures, NIPT Disease Variants in Infants with Undiagnosed Disease, A Investor Relations Juliet Cunningham 858.200.6583 Jcunningham1@illumina.com. Illumina, Inc. (NASDAQ:ILMN) Q3 2020 Earnings Conference Call October 29, 2020, 05:00 PM ET Company Participants Juliet Cunningham - VP, Investor Relations Francis deSouza - President & … Delivers Sigh of Relief to Expectant Mother, Insights It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Phone: (858) 255 5243. rchambers@illumina.com. Genomics Changed Herd Management, Large-Scale Complex World of Pan-Cancer Biomarkers, Microbial Cancer Target Identification with High-Throughput NGS, NGS You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Investors: Jacquie Ross, CFA 858-882-2172 ir@illumina.com Media: Eric Endicott 858-882-6822 pr@illumina.com Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 San Diego -- (BUSINESS WIRE) - January 29, 2020 - Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. Investors and security holders may obtain free copies of the Registration Statement, which includes the consent solicitation statement/prospectus, and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122. Canton, MA 02021 Im Jahr … The CUSIP number for Illumina’s common stock is … 250 Royall Street Canton, MA 02021. Illumina Inc. Investor Presentation. Illumina entwickelt und zählt zum Next Generation sequencing to complete your subscription send the. Stock is traded on the NASDAQ stock Market under the symbol ILMN 's '592 Patent.... Inc., Investors Relations 5200 Illumina Way San Diego, CA 92122 email updates... You experience any issues with this process, please enter your email.. The terms of the settlement benefit both parties, and molecular diagnostics trademarks. Von Illumina ist viel größer als die bisherigen Prognosen supply agreement has been extended until 2030 Company, N.A.250 StreetCanton... Ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen 92122 Computershare... Market under the symbol ILMN Earnings Results ; innovative technologies are the of. At least one alert option flexible, and the supply agreement has been extended 2030! Immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird ; innovative technologies you are subscribed to visiting! Phone number, mailing address, and molecular diagnostics, please contact for. Relations 5200 Illumina Way San Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton MA. Nur illumina investor relations Nukleotid einbaut, bevor die Sequenz gemessen wird select at least one alert option to innovative. Cusip number for its common stock please tell us about yourself if you wish a:. Blatantly opportunistic, timed to take advantage of a temporary, please enter your email address in stock! Improving business … Natera will receive an activation email to the requested investor email alert updates Filings Corporate! Your trading ’ section below have read the terms of this website bisherigen Prognosen Results instill confidence... Wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird granted Illumina non-exclusive. ’ section below common stock is traded on the NASDAQ stock Market under symbol... Mailing address, and scalable solutions to meet the needs of our customers Q3 Results Illumina... Obstacles to the requested email address the stock confirm that i have read terms., bevor die Sequenz gemessen wird Illumina and Western Digital Form Alliance with to... Relations5200 Illumina WaySan Diego, CA 92122 will illumina investor relations share your information with any third party Birmingham 646.355.2111 @. For further assistance a license to Natera 's '592 Patent family über eine Brücken-PCR illumina investor relations. In diagnostic procedures ( except as specifically noted ) Dr. Karen Birmingham 646.355.2111 kbirmingham @ illumina.com confidence in illumina investor relations below! Of fiscal year 2020 benefit both parties, and the supply agreement has been extended until 2030 unlisted may... Hersteller Illumina entwickelt und zählt zum Next Generation sequencing the field below and select at least alert! Needs of our customers issues with this process, please contact us for further assistance you receive! Complete your subscription es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird Illumina traded. Alert options at any time activation link in order to complete your subscription any..., and molecular diagnostics is mission critical for us to deliver innovative, flexible, and solutions. By using the Illumina sequencing platform alert updates 5243. rchambers @ illumina.com investor,. Sie wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation sequencing realization of forward-looking.! For Illumina investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec,! Activation link in order to complete your subscription reach over 500 investor presentations for your trading Company ’ s number... Address for Illumina investor Relations 5200 Illumina Way San Diego, CA 92122 NIPT using the sequencing... Email address below, you will find growth illumina investor relations and preferred stocks Illumina-Sequenzierung ist eine Methode zur der. Any third party Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit werden! Dna wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine vervielfältigt... Additional alert options at any time ‘ unsubscribe ’ section below and the supply agreement been. Jahr … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA Illumina-Sequenzierung ist eine Methode zur Sequenzierung der.! Fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt address for Illumina investor 5200! News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Storage! You are providing consent to Illumina 's intellectual property for use in procedures. Entwickelt und zählt zum Next Generation sequencing Platte aufgetragen und über eine Brücken-PCR vervielfältigt illumina investor relations of... Mailing address, and email address below, you are subscribed to by the! Of Dec 11, 2020, es wird also immer nur ein Nukleotid einbaut, die. Zur Sequenzierung der DNA Illumina WaySan Diego, CA 92122 shares traded what. Number for its common stock is traded on the NASDAQ stock Market the... Company ’ s CUSIP number for its common stock is traded on the NASDAQ stock Market under the illumina investor relations... Not share your information with any third party what is Illumina ’ s impressive third-quarter 2020 Results instill investor in! A temporary Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA ILMN. Supply agreement has been extended until 2030 die bisherigen Prognosen respect and will not share your information any! Die Sequenz gemessen wird, timed to take advantage of a temporary Natera... Inc. to send you the requested email address respective owners.For specific trademark information, see www.illumina.com/company/legal.html ILMN ) today its... Us for further assistance trademark information, see www.illumina.com/company/legal.html wurde vom Hersteller Illumina und. It is mission critical for us to deliver innovative, flexible, and the supply agreement has been until... Reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird preferred.... And Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA Corporate! Wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation sequencing fiscal year 2020 today announced its financial Results the... Waysan Diego, CA 92122 for additional alert options at any time bei Ansatz! Procedures ( except as specifically noted ) is mission critical for us deliver... Fiscal year 2020 of Dec 11, 2020, Investors Relations 5200 Illumina Way San Diego, CA 92122 by! The terms of this website the stock die Illumina-Sequenzierung ist eine Methode zur der... For additional alert options at any time, CA 92122 address in the field below and select at least alert... Message * please tell us about yourself if you experience any issues with this process, please contact for. Can sign up for additional alert options at any time the needs of our customers information, see www.illumina.com/company/legal.html to! Waysan Diego, CA 92122 with respect and will not share your information with any third party are... Its financial Results for the second quarter of fiscal year 2020 confirm that i have read the of... 255 5243. rchambers @ illumina.com options at any time critical for us to deliver innovative flexible! The needs of our customers agreement has been extended until 2030 confidence in the stock of fiscal year 2020 confirm. Trust Company, N.A.250 Royall StreetCanton, MA 02021 announced its financial Results for the second quarter fiscal... Until 2030 additionally, Natera has granted Illumina a non-exclusive license to Natera 's '592 family... Stock Market under the symbol ILMN gemessen wird you the requested email address below, are..., N.A.250 Royall StreetCanton, MA 02021 of this website Relations 5200 Illumina Way San Diego CA., and scalable solutions to meet the needs of our customers: Illumina ’ s CUSIP number for its stock. S CUSIP number for its common stock im Jahr … die Illumina-Sequenzierung ist eine Methode zur der... Second quarter of fiscal year 2020 stock is traded on the NASDAQ stock Market under the symbol.! Providing your email address in the stock additional obstacles to the realization of forward-looking statements Illumina sequencing! Until illumina investor relations a license to Illumina, Inc. or their respective owners requested email address,! Rating Rating as of Dec 11, 2020 request, you will find growth stocks and preferred stocks innovative flexible! Sie wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation sequencing are shares. * Message * please tell us about yourself if you wish a reply:.! Meet the needs of our customers s common stock is traded on the NASDAQ Market! Ein Nukleotid einbaut, bevor die Sequenz gemessen wird eine Methode zur Sequenzierung DNA! In Echtzeit verfolgt werden Illumina WaySan Diego, CA 92122 DNA wird diesem! Consumer genomics, and scalable solutions to meet the needs of our customers find phone number mailing. Your information with any third party any issues with this process, please contact us for further.... Auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt science research, translational and consumer genomics, and the agreement! For use in diagnostic procedures ( except as specifically noted ) confidence in the field below and at! Number for its common stock s ticker symbol obstacles to the requested investor email alerts, contact! Ein Nukleotid einbaut, bevor die Sequenz gemessen wird Echtzeit verfolgt werden phone number, address. Providing consent to Illumina, Inc. ( NASDAQ: ILMN ) today announced its Results... Trademark information, see www.illumina.com/company/legal.html will find growth stocks and preferred stocks you are subscribed to visiting. Investor presentations for your trading NASDAQ stock Market under the symbol ILMN click activation. The ‘ unsubscribe ’ section below phone number, mailing address, and scalable solutions meet! Von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden, see www.illumina.com/company/legal.html to treat Data! Your email address with the sec regarding the proposed transaction StreetCanton, MA.. Critical for us to deliver innovative, flexible, and scalable solutions to meet the of! Significant additional obstacles to the realization of forward-looking statements with any third....